Arrowhead Pharmaceuticals, Inc.

ROYAL BANK OF CANADA ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

51,196

Value ($000)

3,399

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	3,399	0.0%	51,196	12/31/2025
2025 Q2	8/14/2025	6,323	0.0%	400,210	6/30/2025
2025 Q1	11/21/2025	576	0.0%	45,239	3/31/2025
2024 Q4	2/14/2025	653	0.0%	34,743	12/31/2024
2024 Q3	11/14/2024	632	0.0%	32,671	9/30/2024
2024 Q2	11/6/2024	867	0.0%	33,367	6/30/2024
2024 Q1	11/5/2024	1,004	0.0%	35,109	3/31/2024
2023 Q4	2/14/2024	1,537	0.0%	50,273	12/31/2023
2023 Q3	11/14/2023	910	0.0%	33,837	9/30/2023
2023 Q2	8/14/2023	1,579	0.0%	44,301	6/30/2023
2023 Q1	5/15/2023	537	0.0%	21,170	3/31/2023
2022 Q4	2/14/2023	3,369	0.0%	83,058	12/31/2022
2022 Q3	11/14/2022	2,122	0.0%	64,256	9/30/2022
2022 Q2	8/15/2022	2,136	0.0%	60,672	6/30/2022
2022 Q1	5/16/2022	2,763	0.0%	60,074	3/31/2022
2021 Q4	2/14/2022	5,828	0.0%	87,896	12/31/2021
2021 Q3	11/15/2021	4,411	0.0%	70,633	9/30/2021
2021 Q2	8/16/2021	5,025	0.0%	60,673	6/30/2021
2021 Q1	7/20/2021	4,715	0.0%	71,098	3/31/2021
2020 Q4	2/16/2021	6,693	0.0%	87,240	12/31/2020
2020 Q3	11/16/2020	4,401	0.0%	105,903	9/30/2020
2020 Q2	8/14/2020	5,857	0.0%	135,603	6/30/2020
2020 Q1	6/16/2020	3,378	0.0%	117,374	3/31/2020
2019 Q4	2/14/2020	7,803	0.0%	123,030	12/31/2019